EXOMIND’s patented ExoTMS technology is built on the foundation of Transcranial Magnetic Stimulation, a well-established and noninvasive therapy that has been studied for decades in the treatment of Major Depressive Disorder.
FDA-cleared for the treatment of depression†, anxiety, and OCD. EXOMIND’s patented ExoTMS™ technology comfortably stimulates key areas of the brain involved in emotional regulation, cognitive function, and self-control. By activating neural pathways, it helps restore healthy brain activity and enhances neural connectivity.
EXOMIND’s patented ExoTMS technology is built on the foundation of Transcranial Magnetic Stimulation, a well-established and noninvasive therapy that has been studied for decades in the treatment of Major Depressive Disorder.
FDA-cleared for the treatment of depression†, anxiety, and OCD. EXOMIND’s patented ExoTMS™ technology comfortably stimulates key areas of the brain involved in emotional regulation, cognitive function, and self-control. By activating neural pathways, it helps restore healthy brain activity and enhances neural connectivity.
